Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
Neurobiology of Disease|February 3, 2005
Inhibition of P53-related apoptosis had no effect on PrP(Sc) accumulation and prion disease incubation timeRoni Engelstein, Nikolas Grigoriadis, Nigel H Greig, et al.Brain Research|December 4, 2003
Copper binding to PrPC may inhibit prion disease propagationNuha Hijazi, Yuval Shaked, Hana Rosenmann, et al.Annals of Neurology|September 27, 2002
Valproic acid treatment results in increased accumulation of prion proteinsGideon M Shaked, Roni Engelstein, Inbal Avraham, et al.Journal of Neuroimmunology|April 19, 2005
Characterization of light chain immunoglobulin in urine from animals and humans infected with prion diseasesZehavit Kariv-Inbal, Michele Halimi, Yael Dayan, et al.Brain Research|August 14, 2003
Dimethyl sulfoxide delays PrP sc accumulation and disease symptoms in prion-infected hamstersGideon M Shaked, Roni Engelstein, Inbal Avraham, et al.Human Molecular Genetics|March 27, 2014
Genetic prion disease: no role for the immune system in disease pathogenesis?Yael Friedman-Levi, Orli Binyamin, Kati Frid, et al.Plos One|August 8, 2013
PrP(ST), a soluble, protease resistant and truncated PrP form features in the pathogenesis of a genetic prion diseaseYael Friedman-Levi, Michal Mizrahi, Kati Frid, et al.Cellular and Molecular Life Sciences : CMLS|May 11, 2010
The structural intolerance of the PrP alpha-fold for polar substitution of the helix-3 methioninesSilvia Lisa, Massimiliano Meli, Gema Cabello, et al.Scientific Reports|December 6, 2019
Brain targeting of 9c,11t-Conjugated Linoleic Acid, a natural calpain inhibitor, preserves memory and reduces Aβ and P25 accumulation in 5XFAD miceOrli Binyamin, Keren Nitzan, Kati Frid, et al.Neurobiology of Disease|August 30, 2017
Continues administration of Nano-PSO significantly increased survival of genetic CJD miceOrli Binyamin, Guy Keller, Kati Frid, et al.Pageof 5